Table of Contents
ISRN Gastroenterology
Volume 2013 (2013), Article ID 612037, 9 pages
http://dx.doi.org/10.1155/2013/612037
Research Article

Hemin and Zinc Protoporphyrin IX Affect Granisetron Constipating Effects In Vitro and In Vivo

Department of Biomedical Sciences and Human Oncology, Pharmacology Section, Medical School, University of Bari “Aldo Moro”, Piazza Giulio Cesare, 70124 Bari, Italy

Received 24 April 2013; Accepted 5 June 2013

Academic Editors: A. Amedei, A. J. Karayiannakis, C.-T. Shun, and C. Sperti

Copyright © 2013 Addolorata Zigrino et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. R. Blower, “Granisetron: relating pharmacology to clinical efficacy,” Supportive Care in Cancer, vol. 11, no. 2, pp. 93–100, 2003. View at Google Scholar · View at Scopus
  2. A. Billio, E. Morello, and M. J. Clarke, “Serotonin receptor antagonists for highly emetogenic chemotherapy in adults,” Cochrane Database of Systematic Reviews, no. 1, article CD006272, 2010. View at Google Scholar · View at Scopus
  3. C. Rojas and B. S. Slusher, “Pharmacological mechanisms of 5-HT3 and tachykinin NK1 receptor antagonism to prevent chemotherapy-induced nausea and vomiting,” The European Journal of Pharmacology, vol. 684, no. 1–3, pp. 1–7, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. R. de Giorgio, G. Barbara, J. B. Furness, and M. Tonini, “Novel therapeutic targets for enteric nervous system disorders,” Trends in Pharmacological Sciences, vol. 28, no. 9, pp. 473–481, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. J. H. Lewis, “The risk of ischaemic colitis in irritable bowel syndrome patients treated with serotonergic therapies,” Drug Safety, vol. 34, no. 7, pp. 545–565, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. M. S. Kasparek, D. R. Linden, M. E. Kreis, and M. G. Sarr, “Gasotransmitters in the gastrointestinal tract,” Surgery, vol. 143, no. 4, pp. 455–459, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. R. Zakhary, K. D. Poss, S. R. Jaffrey, C. D. Ferris, S. Tonegawa, and S. H. Snyder, “Targeted gene deletion of heme oxygenase 2 reveals neural role for carbon monoxide,” Proceedings of the National Academy of Sciences of the United States of America, vol. 94, no. 26, pp. 14848–14853, 1997. View at Publisher · View at Google Scholar · View at Scopus
  8. L. Wu and R. Wang, “Carbon monoxide: endogenous production, physiological functions, and pharmacological applications,” Pharmacological Reviews, vol. 57, no. 4, pp. 585–630, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. Y. Naito, T. Takagi, K. Uchiyama, and T. Yoshikawa, “Heme oxygenase-1: a novel therapeutic target for gastrointestinal diseases,” Journal of Clinical Biochemistry and Nutrition, vol. 48, no. 2, pp. 126–133, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. A. L. Piepoli, G. de Salvatore, M. Lemoli, L. de Benedictis, D. Mitolo-Chieppa, and M. A. de Salvia, “Modulation of heme oxygenase/carbon monoxide system affects the inhibitory neurotransmission involved in gastrointestinal motility of streptozotocin-treated diabetic rats,” Neurogastroenterology and Motility, vol. 20, no. 11, pp. 1251–1262, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. L. de Benedictis, M. A. Potenza, S. Gagliardi, A. Zigrino, M. Montagnani, and M. A. de Salvia, “Rosiglitazone reverses increased duodenal inhibitory response in spontaneously hypertensive rats,” Neurogastroenterology and Motility, vol. 24, no. 1, pp. e56–e66, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. D. Mitolo-Chieppa, G. Mansi, C. Nacci et al., “Idiopathic chronic constipation: tachykinins as cotransmitters in colonic contraction,” European Journal of Clinical Investigation, vol. 31, no. 4, pp. 349–355, 2001. View at Publisher · View at Google Scholar · View at Scopus
  13. R. Motterlini, A. Gonzales, R. Foresti, J. E. Clark, C. J. Green, and R. M. Winslow, “Heme oxygenase-1-derived carbon monoxide contributes to the suppression of acute hypertensive responses in vivo,” Circulation Research, vol. 83, no. 5, pp. 568–577, 1998. View at Google Scholar · View at Scopus
  14. H. T. Gan and J. D. Z. Chen, “Induction of heme oxygenase-1 improves impaired intestinal transit after burn injury,” Surgery, vol. 141, no. 3, pp. 385–393, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. L. Shim, N. J. Talley, P. Boyce, C. Tennant, M. Jones, and J. E. Kellow, “Stool characteristics and colonic transit in irritable bowel syndrome: evaluation at two time points,” Scandinavian Journal of Gastroenterology, vol. 48, no. 3, pp. 295–301, 2013. View at Google Scholar
  16. H. R. N. Marona and M. B. B. Lucchesi, “Protocol to refine intestinal motility test in mice,” Laboratory Animals, vol. 38, no. 3, pp. 257–260, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. T. Saito, F. Mizutani, Y. Iwanaga, K. Morikawa, and H. Kato, “Laxative and anti-diarrheal activity of polycarbophil in mice and rats,” The Japanese Journal of Pharmacology, vol. 89, no. 2, pp. 133–141, 2002. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Hidaka, Y.-T. Azuma, H. Nakajima, and T. Takeuchi, “Nitric oxide and carbon monoxide act as inhibitory neurotransmitters in the longitudinal muscle of C57BL/6J mouse distal colon,” Journal of Pharmacological Sciences, vol. 112, no. 2, pp. 231–241, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. M. G. Cutler and S. Arrol, “Pharmacological effects of haem biosynthetic intermediates in isolated intestinal preparations,” The European Journal of Pharmacology, vol. 134, no. 3, pp. 249–256, 1987. View at Google Scholar · View at Scopus
  20. B. R. Tuladhar, M. Kaisar, and R. J. Naylor, “Evidence for a 5-HT3 receptor involvement in the facilitation of peristalsis on mucosal application of 5-HT in the guinea pig isolated ileum,” The British Journal of Pharmacology, vol. 122, no. 6, pp. 1174–1178, 1997. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Bortscher, J. Chang, T. O. Vilz et al., “Hemin induction of HO-1 protects against LPS-induced septic ileus,” The Journal of Surgical Research, vol. 178, no. 2, pp. 866–873, 2012. View at Google Scholar
  22. H. Wolf, “Preclinical and clinical pharmacology of the 5-HT3 receptor antagonists,” Scandinavian Journal of Rheumatology Supplement, vol. 29, no. 113, pp. 37–45, 2000. View at Google Scholar · View at Scopus
  23. J. Carmichael, H. J. Keizer, D. Cupissol, J. Milliez, P. Scheidel, and A. E. Schindler, “Use of granisetron in patients refractory to previous treatment with antiemetics,” Anti-Cancer Drugs, vol. 9, no. 5, pp. 381–385, 1998. View at Publisher · View at Google Scholar · View at Scopus
  24. E. S. Björnsson, W. D. Chey, F. Hooper, M. L. Woods, C. Owyang, and W. L. Hasler, “Impaired gastrocolonic response and peristaltic reflex in slow-transit constipation: role of 5-HT3 pathways,” American Journal of Physiology, Gastrointestinal and Liver Physiology, vol. 283, no. 2, pp. G400–G407, 2002. View at Google Scholar · View at Scopus
  25. K. A. Alkadhi, R. S. Al-Hijailan, K. Malik, and Y. H. Hogan, “Retrograde carbon monoxide is required for induction of long-term potentiation in rat superior cervical ganglion,” Journal of Neuroscience, vol. 21, no. 10, pp. 3515–3520, 2001. View at Google Scholar · View at Scopus
  26. T. J. Gan, “Selective serotonin 5-HT3 receptor antagonists for postoperative nausea and vomiting: are they all the same?” CNS Drugs, vol. 19, no. 3, pp. 225–238, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. L. Guan, T. Wen, Y. Zhang, X. Wang, and J. Zhao, “Induction of heme oxygenase-1 with hemin attenuates hippocampal injury in rats after acute carbon monoxide poisoning,” Toxicology, vol. 262, no. 2, pp. 146–152, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. P. A. Hosick and D. E. Stec, “Heme oxygenase, a novel target for the treatment of hypertension and obesity?” American Journal of Physiology, Regulatory Integrative and Comparative Physiology, vol. 302, no. 2, pp. R207–R214, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. Y. Joe, M. Zheng, S.-K. Kim et al., “The role of carbon monoxide in metabolic disease,” Annals of the New York Academy of Sciences, vol. 1229, no. 1, pp. 156–161, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. N. K. Idriss, A. D. Blann, and G. Y. H. Lip, “Hemoxygenase-1 in cardiovascular disease,” Journal of the American College of Cardiology, vol. 52, no. 12, pp. 971–978, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. B. S. Zuckerbraun, L. E. Otterbein, P. Boyle et al., “Carbon monoxide protects against the development of experimental necrotizing enterocolitis,” American Journal of Physiology, Gastrointestinal and Liver Physiology, vol. 289, no. 3, pp. G607–G613, 2005. View at Publisher · View at Google Scholar · View at Scopus
  32. K. Sato, J. Balla, L. Otterbein et al., “Carbon monoxide generated by heme oxygenase-1 suppresses the rejection of mouse-to-rat cardiac transplants,” Journal of Immunology, vol. 166, no. 6, pp. 4185–4194, 2001. View at Google Scholar · View at Scopus
  33. S. W. Ryter and A. M. K. Choi, “Heme oxygenase-1/carbon monoxide: from metabolism to molecular therapy,” The American Journal of Respiratory Cell and Molecular Biology, vol. 41, no. 3, pp. 251–260, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. A. Nakao, K. Kimizuka, D. B. Stolz et al., “Carbon monoxide inhalation protects rat intestinal grafts from ischemia/reperfusion injury,” The American Journal of Pathology, vol. 163, no. 4, pp. 1587–1598, 2003. View at Google Scholar · View at Scopus
  35. P. Kashyap and G. Farrugia, “Diabetic gastroparesis: what we have learned and had to unlearn in the past 5 years,” Gut, vol. 59, no. 12, pp. 1716–1726, 2010. View at Publisher · View at Google Scholar · View at Scopus
  36. J. Fang, T. Sawa, T. Akaike, K. Greish, and H. Maeda, “Enhancement of chemotherapeutic response of tumor cells by a heme oxygenase inhibitor, pegylated zinc protoporphyrin,” International Journal of Cancer, vol. 109, no. 1, pp. 1–8, 2004. View at Publisher · View at Google Scholar · View at Scopus
  37. Y. Yin, Q. Liu, B. Wang, G. Chen, L. Xu, and H. Zhou, “Expression and function of heme oxygenase-1 in human gastric cancer,” Experimental Biology and Medicine, vol. 237, no. 4, pp. 362–371, 2012. View at Publisher · View at Google Scholar · View at Scopus
  38. M. Shimizu and A. Yachie, “Compensated inflammation in systemic juvenile idiopathic arthritis: role of alternatively activated macrophages,” Cytokine, vol. 60, no. 1, pp. 226–232, 2012. View at Google Scholar
  39. S. Mumby, R. L. Upton, Y. Chen et al., “Lung heme oxygenase-1 is elevated in acute respiratory distress syndrome,” Critical Care Medicine, vol. 32, no. 5, pp. 1130–1135, 2004. View at Publisher · View at Google Scholar · View at Scopus